AIIMS Rishikesh & Jodhpur NO - 2017
Pharmacology
Easy

Which is the long acting insulin?

Appeared in: AIIMS Rishikesh & Jodhpur NO - 2017

Explanation

  • Glargine is classified as a long-acting insulin.
  • It has an onset of action of 1-2 hours, no pronounced peak, and a duration of action that lasts up to 24 hours.
  • This profile provides a steady, basal insulin level, which is crucial for maintaining glycemic control between meals and overnight.
  • Its unique property of forming microprecipitates at the injection site allows for slow, continuous absorption into the bloodstream.

Why Other Options Were Wrong

  • Option B: NPH (Neutral Protamine Hagedorn) is an intermediate-acting insulin, not long-acting. Its duration is 10-18 hours, and it has a distinct peak, which increases the risk of hypoglycemia compared to long-acting insulins.
  • Option C: Regular insulin is a short-acting insulin. It is used to cover insulin needs for meals eaten within 30-60 minutes and has a duration of 6-10 hours.
  • Option D: Lispro is a rapid-acting insulin. It begins to work in about 15 minutes and is used to control blood sugar spikes from meals. Its duration is only 3-5 hours.

Related Visual

Visual explanation — Related Visual
Clinical Relevance
  • Nursing practice connection: This is primarily an exam-oriented knowledge point with limited direct bedside application, so retain Pharmacology of Insulin Types as background academic context rather than a clinical decision trigger.
  • Understanding the different action profiles of insulin is fundamental for safe and effective diabetes management. Administering the wrong type of insulin can lead to severe hypoglycemia or hyperglycemia.
  • Nurses must educate patients on the correct timing of insulin injections relative to meals based on the insulin type. For example, Lispro is taken just before a meal, while Glargine can be taken once daily regardless of meal times.
  • A common and dangerous error is confusing long-acting and short-acting insulins. A patient receiving a large dose of rapid-acting insulin (like Lispro) instead of their long-acting basal insulin (like Glargine) is at high risk for severe, life-threatening hypoglycemia.
How to Approach the Question
  • First, identify the key term in the question: 'long acting insulin'.
  • This is a factual recall question that requires knowledge of pharmacological classifications.
  • Mentally review or recall the different categories of insulin: rapid-acting, short-acting, intermediate-acting, and long-acting.
  • Categorize each of the given options: Lispro (rapid), Regular (short), NPH (intermediate), and Glargine (long).
  • Select the option that matches the category asked for in the question.
Concept Tested & Keywords
  • Concept Tested: Pharmacology of Insulin Types
  • Stem keywords: long acting insulin
  • Lead-in keywords: Which is
  • Negative lead-in flag: false

Question ID

QLIwUuC-wYYS6S13AdbKt_

Reference Book

E6 Textbook of Biochemistry for medical StudentsDM Vasudevan Part 1 (pp 26-370 of 370) p. 202-204

E6 Medicine Harrison 22e Part 2 p. 1114-1116

E6 Pharmacology Nursing Lilley 11e Part 2 p. 202-204

Practise the full AIIMS Rishikesh & Jodhpur NO - 2017

Attempt every question from this paper in a timed mock, then review the full solution for each one.

More Hormones & Related Drugs Questions

More AIIMS Rishikesh & Jodhpur NO - 2017 Questions